Carvedilol and Hydrochlorothiazide in Hypertensives with Metabolic Disorder: Not Always Bad News - An Austrian Survey

Zweiker R; Perl S; Sock S; Stoschitzky K; Plank J; Kvas E

Zweiker R, Perl S, Sock S, Stoschitzky K, Plank J, Kvas E
Carvedilol and Hydrochlorothiazide in Hypertensives with Metabolic Disorder: Not Always Bad News - An Austrian Survey
Journal für Hypertonie - Austrian Journal of Hypertension 2009; 13 (2): 22-26

Volltext (PDF) Summary Praxisrelevanz Übersicht

Abbildung 3: Cardiovascular Risk
Improvement of cardiovascular risk in diabetic study population using the New Zealand risk score. VO: time of inclusion; V4; follow-up visit.

Vorheriges Bild

Nächstes Bild

Abbildung 3: Cardiovascular Risk
Improvement of cardiovascular risk in diabetic study population using the New Zealand risk score. VO: time of inclusion; V4; follow-up visit.